Intraperitoneal tumor growth and chemotherapy in a rat model

Area of Science:

• Oncology
• Pharmacology
• Animal Models

Background:

• Evaluating new cancer treatment modalities requires effective animal models.
• Peritoneal carcinomatosis presents challenges for systemic drug delivery.
• Existing models may not accurately replicate human peritoneal disease.

Purpose of the Study:

• To describe a new rat model for studying intraperitoneal (i.p.) cytostatic drug administration.
• To evaluate the efficacy of i.p. chemotherapy in a peritoneal cancer model.
• To compare i.p. versus intravenous (i.v.) drug delivery routes.

Main Methods:

• Development of a CC531 chemically induced carcinoma rat model.
• Intraperitoneal inoculation of CC531 cells in Wag/Rij rats.
• Administration of various cytostatic drugs (cisplatin, carboplatin, 5-FU, doxorubicin, mitoxantrone) via i.p. and i.v. routes.
• Assessment of tumor growth, localization, platinum concentration, and survival rates.

Main Results:

• The model successfully replicates peritoneal carcinomatosis in 80% of rats.
• Tumor characteristics in the model resemble human minimal residual disease ovarian carcinoma.
• Intraperitoneal cisplatin administration significantly increased tumor platinum concentrations and prolonged survival compared to i.v. administration.
• The model facilitates pharmacokinetic and drug penetration studies for i.p. administration.

Conclusions:

• The described rat model is suitable for evaluating i.p. chemotherapy against peritoneal cancers.
• Intraperitoneal drug delivery offers advantages over i.v. administration for peritoneal disease.
• This model provides a valuable platform for preclinical research in peritoneal oncology.